Coya Therapeutics (COYA) Net Margin Growth (1y) (2024 - 2026)

Coya Therapeutics (COYA) Net Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn 1,491.00
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn -653.00
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn 447.00
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 2,072.00
10 Coya Therapeutics 97.82 Mn 47.10 Mn - -3,628.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,628.00
Dec 31, 2025 62.53 Mn
Jun 30, 2025 -364,075.00
Mar 31, 2025 114,961.00
Dec 31, 2024 -62.54 Mn